AbbVie (ABBV) Gross Margin (2012 - 2026)

AbbVie (ABBV) has 15 years of Gross Margin data on file, last reported at 71.88% in Q1 2026.

• Gross Margin for Q1 2026 came in at 71.88%, up 188.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 70.68% (down 2.0% YoY), and the FY2025 annual result was 70.24%, up 24.0% from the prior year.
• Gross Margin eased to 71.88% in Q1 2026 per ABBV's latest filing, from 72.61% in the prior quarter.
• Over five years, Gross Margin peaked at 72.61% in Q4 2025 and troughed at 53.44% in Q3 2023.
• A 5-year average of 68.38% and a median of 70.07% in 2022 frame the typical range for Gross Margin.
• The sharpest annual moves came in 2023 and 2024: Gross Margin tumbled 1266 bps in 2023, then soared 1744 bps in 2024.
• A 5-year view of Gross Margin shows it stood at 72.42% in 2022, then slipped by 17 bps to 60.11% in 2023, then increased by 18 bps to 70.89% in 2024, then gained by 2 bps to 72.61% in 2025, then dropped by 1 bps to 71.88% in 2026.
• Business Quant data shows ABBV's Gross Margin at 71.88% in Q1 2026, 72.61% in Q4 2025, and 66.38% in Q3 2025.